Pacer Advisors, Inc. Akebia Therapeutics, Inc. Transaction History

Pacer Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$2.83 - $4.2 $61,139 - $90,736	-21,604 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$2.92 - $5.06 $58,826 - $101,938	-20,146 Reduced 48.25%	21,604 $73,000
Q4 2020 Jan 20, 2021	BUY	$2.22 - $3.78 $82,211 - $139,980	37,032 Added 784.91%	41,750 $117,000
Q3 2020 Oct 19, 2020	BUY	$2.39 - $13.08 $11,276 - $61,711	4,718 New	4,718 $12,000
Q4 2018 Feb 13, 2019	SELL	$5.39 - $9.15 $26,173 - $44,432	-4,856 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$7.44 - $10.65 $36,128 - $51,716	4,856 New	4,856 $43,000
Q1 2018 May 14, 2018	SELL	$9.53 - $15.68 $8,577 - $14,112	-900 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$14.24 - $19.59 $12,816 - $17,631	900	900 $13,000

120

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $324M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.